Trials / Recruiting
RecruitingNCT06294184
TDCS Interventions for Subthreshold Depressive Symptoms in Young Individuals.
Transcranial Direct Current Stimulation Interventions for Subthreshold Depressive Symptoms in Young Individuals.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Guangzhou Psychiatric Hospital · Other Government
- Sex
- All
- Age
- 12 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the mechanisms of the effect of transcranial direct current stimulation (tDCS) in alleviating subthreshold depressive symptoms in young individuals, and individualized outcome prediction is carried out.
Detailed description
After being informed about the study and potential risks, all participants providing written informed consent will undergo screening to determine eligibility for study entry. On day 0, participants who meet the eligibility requirements will be randomized in a double-blind manner (participant and investigator) in a 1:1:1 ratio to receive tDCS targeting the left dorsolateral prefrontal cortex (lDLPFC), tDCS targeting the right ventrolateral prefrontal cortex (rVLPFC), or Sham stimulation (10 sessions in 2 weeks). At baseline, after 2 weeks of stimulation, and at follow-up after 1 month and 3 months, participants will be assessed for brain network function, depressive symptoms, emotional status and social interactions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | tdcs lDLPFC | The current is 2mA, duration is 1200s, fade in 30s, fade out 30s, anode is on the F3, cathode is on the FP2. |
| DEVICE | tdcs rVLPFC | The current is 2mA, duration is 1200s, fade in 30s, fade out 30s, anode is on the F6, cathode is on the FP1. |
| DEVICE | Sham | The current only persist in the fisrt 30s, duration is 1200s, fade in 30s, fade out 30s, anode is on the F3/F6, cathode is on the FP2/1. |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2024-03-05
- Last updated
- 2024-12-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06294184. Inclusion in this directory is not an endorsement.